These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1571265)

  • 1. Fixed drug eruption to mefenamic acid: a report of three cases.
    Long CC; Finlay AY; Marks R
    Br J Dermatol; 1992 Apr; 126(4):409-11. PubMed ID: 1571265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
    Nor Azlin MI; Maryasalwati I; Norzilawati MN; Mahdy ZA; Jamil MA; Zainul Rashid MR
    J Obstet Gynaecol; 2008 May; 28(4):424-6. PubMed ID: 18604680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Dalmatian dog'-like skin eruption (two cases of multifocal fixed drug eruption induced by mefenamic acid).
    Rallis E; Rigopoulos D; Anyfantakis V; Kalogirou O; Christophidou E; Papadakis P; Katsambas A
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):753-5. PubMed ID: 16268887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of tiaprofenic acid, mefenamic acid and placebo in the treatment of dysmenorrhoea in general practice.
    Tilyard MW; Dovey SM
    Aust N Z J Obstet Gynaecol; 1992 May; 32(2):165-8. PubMed ID: 1520205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of the efficacy of mefenamic acid in relief of menorrhagia and/or dysmenorrhoea.
    Vairojanavong K; Limchitti D; Sasivimolkul V
    J Med Assoc Thai; 1983 Feb; 66(2):99-105. PubMed ID: 6343540
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.
    Anderson AB; Haynes PJ; Fraser IS; Turnbull AC
    Lancet; 1978 Feb; 1(8060):345-8. PubMed ID: 75391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
    de Mello NR; Baracat EC; Tomaz G; Bedone AJ; Camargos A; Barbosa IC; de Souza RN; Rumi DO; Martinez Alcala FO; Velasco JA; Cortes RJ
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):667-73. PubMed ID: 15225193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
    Roy S
    Obstet Gynecol; 1983 May; 61(5):628-32. PubMed ID: 6835617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
    Hébert JG; Le Morvan P; Bourgouin J
    Clin Ther; 1986; 8(3):329-35. PubMed ID: 3521860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulated multifocal fixed drug eruption due to mefenamic acid - a new morphological pattern.
    Dar NR; Masood S; Mustafvi SA
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):562-3. PubMed ID: 16181578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity between nonsteroidal anti-inflammatory drugs in fixed drug eruption: Two unusual cases and a literature review.
    Ammar H; Ben Fredj N; Ben Romdhane H; Chaabane A; Chadli Z; Ben Fadhel N; Aouam K
    Br J Clin Pharmacol; 2023 Feb; 89(2):561-573. PubMed ID: 36223303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea.
    Langrick AF; Gunn AD; Livesey H; Whitehead AM
    Br J Clin Pract; 1989 Sep; 43(9):317-21. PubMed ID: 2620043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E; von Fischer B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1487-93. PubMed ID: 6769316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal fixed drug eruption due to mefenamic acid: Report of a case and a review.
    Zaouak A; Ben Brahim E; Ben Tanfous A; Koubaa W; Sahnoun R; Hammami H; Fenniche S
    Therapie; 2018 Oct; 73(5):433-435. PubMed ID: 29525693
    [No Abstract]   [Full Text] [Related]  

  • 15. Fixed drug eruption caused by mefenamic acid: a case series and diagnostic algorithms.
    Handisurya A; Moritz KB; Riedl E; Reinisch C; Stingl G; Wöhrl S
    J Dtsch Dermatol Ges; 2011 May; 9(5):374-8. PubMed ID: 21366861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of mefenamic acid in primary dysmenorrhea.
    Wenzloff NJ
    Clin Pharm; 1982; 1(6):497. PubMed ID: 7185537
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of primary dysmenorrhea with mefenamic acid.
    Kintis GA; Coutifaris B
    Int J Gynaecol Obstet; 1980; 18(3):172-5. PubMed ID: 6109648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal fixed drug eruption mimicking erythema multiforme.
    Sowden JM; Smith AG
    Clin Exp Dermatol; 1990 Sep; 15(5):387-8. PubMed ID: 2146052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib versus mefenamic acid in the treatment of primary dysmenorrhea.
    Basri NI; Abd Ghani NA; Mahdy ZA; Abdul Manaf MR; Mohamed Ismail NA
    Horm Mol Biol Clin Investig; 2020 Apr; 41(3):. PubMed ID: 32304300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefenamic acid therapy in dysmenorrhea.
    Budoff PW
    Adv Prostaglandin Thromboxane Res; 1980; 8():1449-53. PubMed ID: 6155061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.